Showing results (91-100 of 157) with videos related to

Sort By:
Pageof 16
Revista Do Instituto De Medicina Tropical De Sao Paulo|July 5, 2018
Prevalence of schistosomiasis mansoni in indigenous Maxakali villages, Minas Gerais, BrazilMaria Beatriz Pena E Silva Leite Nacife, Liliane Maria Vidal Siqueira, Rafael Martins, et al.
Cancers|November 9, 2024
Predicting Additional Metastases in Axillary Lymph Node Dissection After Neoadjuvant Chemotherapy: Ratio of Positive/Total Sentinel NodesIsaac Cebrecos, Ines Torras, Helena Castillo, et al.
BMC Medicine|December 20, 2015
Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapyAleix Prat, Cheng Fan, Aranzazu Fernández, et al.
Acta Cirurgica Brasileira|December 10, 2013
The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factorsSuerda Guiomar Feijó, José Milton de Castro Lima, Maria Aparecida Alves de Oliveira, et al.
International Journal of Cardiology. Heart & Vasculature|May 6, 2022
"Impact of age on management and prognosis of resuscitated sudden cardiac death patients"Jordi Sans Roselló, Maria Vidal-Burdeus, Pablo Loma-Osorio, et al.
Revista Brasileira De Enfermagem|March 31, 2021
Knowledge and practices of Primary Care professionals on diabetic neuropathy: study of social representationsErlon Gabriel Rego de Andrade, Ivaneide Leal Ataíde Rodrigues, Sidney de Assis da Serra Braga, et al.
Trials|June 14, 2020
Effectiveness of inspiratory muscle training associated with a cardiac rehabilitation program on sympathetic activity and functional capacity in patients with heart failure: a study protocol for a randomized controlled trialJéssica Costa Leite, Daniella Cunha Brandão, Simone Cristina Soares Brandão, et al.
Revista Da Escola De Enfermagem Da U S P|March 15, 2024
Mycobacterium tuberculosis latent infection in healthcare students: systematic review of prevalenceRenata Silva de Lima, Rodrigo Nogueira da Silva, Suzana Rosa André, et al.
The Lancet. Oncology|February 28, 2017
HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trialAntonio Llombart-Cussac, Javier Cortés, Laia Paré, et al.
Cancer Treatment Reviews|July 31, 2024
Hormone receptor-positive early breast cancer in young women: A comprehensive reviewBenjamin Walbaum, Isabel García-Fructuoso, Olga Martínez-Sáez, et al.
Pageof 16